MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms |
Chemotherapy |
C9100 | Acute lymphoblastic leukemia not having achieved remission |
C9101 | Acute lymphoblastic leukemia, in remission |
C9102 | Acute lymphoblastic leukemia, in relapse |
C9200 | Acute myeloblastic leukemia, not having achieved remission |
C9201 | Acute myeloblastic leukemia, in remission |
C9202 | Acute myeloblastic leukemia, in relapse |
C9240 | Acute promyelocytic leukemia, not having achieved remission |
C9241 | Acute promyelocytic leukemia, in remission |
C9242 | Acute promyelocytic leukemia, in relapse |
C9250 | Acute myelomonocytic leukemia, not having achieved remission |
C9251 | Acute myelomonocytic leukemia, in remission |
C9252 | Acute myelomonocytic leukemia, in relapse |
C9260 | Acute myeloid leukemia with 11q23-abnormality not having achieved remission |
C9261 | Acute myeloid leukemia with 11q23-abnormality in remission |
C9262 | Acute myeloid leukemia with 11q23-abnormality in relapse |
C92A0 | Acute myeloid leukemia with multilineage dysplasia, not having achieved remission |
C92A1 | Acute myeloid leukemia with multilineage dysplasia, in remission |
C92A2 | Acute myeloid leukemia with multilineage dysplasia, in relapse |
C9300 | Acute monoblastic/monocytic leukemia, not having achieved remission |
C9301 | Acute monoblastic/monocytic leukemia, in remission |
C9302 | Acute monoblastic/monocytic leukemia, in relapse |
C9400 | Acute erythroid leukemia, not having achieved remission |
C9401 | Acute erythroid leukemia, in remission |
C9402 | Acute erythroid leukemia, in relapse |
C9500 | Acute leukemia of unspecified cell type not having achieved remission |
C9501 | Acute leukemia of unspecified cell type, in remission |
C9502 | Acute leukemia of unspecified cell type, in relapse |
3E03002 | Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach |
3E03302 | Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach |
3E04002 | Introduction of High-dose Interleukin-2 into Central Vein, Open Approach |
3E04302 | Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach |
3E05002 | Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach |
3E05302 | Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach |
3E06002 | Introduction of High-dose Interleukin-2 into Central Artery, Open Approach |
3E06302 | Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach |
3E0R302 | Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach |
3E0S302 | Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach |